Competitive polymerase chain reaction was used to quantitate latent varicella-zoster virus (VZV) DNA in human trigeminal ganglia. Ganglionic DNA from five subjects was amplified with oligonucleotide primers specific for VZV gene 28. Two of the samples were also analyzed with primers specific for VZV gene 62. Our results indicated that there are 6 to 31 copies of the VZV genome in every 100,000 ganglionic cells.
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After primary infection, varicella-zoster virus (VZV) becomes latent in dorsal root ganglia and reactivates decades later to produce zoster (6) . Polymerase chain reaction (PCR) revealed latent VZV DNA in trigeminal ganglia from 13 of 15 (86%) humans and in thoracic ganglia from 9 of 17 (53%) humans; none of three thoracic ganglia from one seronegative individual contained VZV DNA (7) . To develop an understanding of the establishment and maintenance of latency, it is necessary to know the cell type in which virus is latent, its abundance and configuration, and the extent of virus DNA expression. This study addressed the issue of virus DNA abundance during latency. We used a modified version of competitive PCR (5) to determine precisely the number of VZV DNA molecules in human ganglia during latency in comparison with the number in productively infected cells in tissue culture.
One or both trigeminal ganglia were obtained 2 to 24 h after death from five humans who died of illnesses unrelated to VZV infection (Table 1) . Total DNA was extracted from human ganglia and VZV-infected BSC-1 cells as described previously (7) . DNA sequences specific for VZV gene 28 (located in the unique long region of the virus genome) and for VZV gene 62 (located in the inverted repeat sequences bracketing the unique short region of the virus genome) were used for PCR amplifications. VZV genes 28 and 62 are separated by 58 kbp.
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PCR and the analysis of products were performed as described before (7, 8 12-,ul aliquot of the cleaned PCR products was then digested with NcoI for 16 h, separated on a 2% agarose gel, transferred onto a Zeta-probe (Bio-Rad, Richmond, Calif.) membrane, and hybridized with an end-labeled oligonucleotide probe located internal to the amplified DNA segment (7, 8) . The filter was washed and exposed to Kodak X-OMAT film for 5 h at -70°C.
DNA from latently infected human ganglia was mixed with the recombinant clone containing the mutated gene 28 and amplified. NcoI digestion of the products yielded three fragments (250, 175, and 75 bp), two of which (250 and 175 bp) hybridized to the end-labeled oligonucleotide probe. Figure 2 shows the results of quantitative PCR on DNA from the trigeminal ganglia of subject 1. The Zeta-probe (Bio-Rad) membrane containing the radioactive bands was cut out, and the radioactivity was counted by liquid scintillation spectrophotometry. Background counts per minute (cpm) were determined from the no-DNA control (first lane in Fig. 2) .
From the equation Y = A(1 + R)', where Yis the extent of amplification, A is the initial amount of DNA, R is the mean efficiency per cycle, and n is the number of cycles (9) , the relationship between the number of copies of the mutated clone containing VZV gene 28 DNA added to the PCR mixture and the ratio of cpm in the mutant band to cpm in the wild-type band is linear. A first-order line of regression was fitted to the data points obtained by counting the cpm in the respective bands (Fig. 3) . This should generate a 100-bp PCR product. The internal oligonucleotide probe used for detection of the PCR product of VZV gene 62 is located between nucleotides 107861 and 107885 on the virus genome (1) . A mutated single-stranded DNA was then used to determine the copy number of latent VZV DNA in the trigeminal ganglia of subjects 3 and 4 as described for VZV gene 28.
To construct the mutant VZV gene 62, a synthetic 100-nucleotide single-stranded DNA containing an A to T substitution at positions 52 and 53 (corresponding to positions 107887 and 107888 in the VZV genome) was obtained (Operon, Inc.). The substitution in the synthetic 100-mer generated a unique EcoRI site. Whereas the 100-bp PCR product generated from ganglionic DNA (wild type) does not contain an internal EcoRI site, the 100-bp amplification product from the synthetic (mutant) single-stranded DNA produces 54-bp and 46-bp EcoRI fragments. The products were detected and quantitated by using a labeled internal oligonucleotide as described above.
At the end of the first cycle of the competitive PCR, a single copy of a 100-bp double-stranded segment is produced from the mutant single-stranded DNA, whereas four copies of 100-bp double-stranded DNA are produced from wild- Amplification of VZV gene 28-specific sequences from DNA extracted from the trigeminal ganglia of subject 1 and analysis of the products were performed as described in the text. The cpm for each sample was determined by averaging samples from duplicate lanes (see Fig. 2 ). The (Table 1) . Given the ability of PCR to detect small numbers of copies of DNA molecules, these numbers compare favorably with the 10 to 15 copies of VZV gene 28 detected in DNA from the trigeminal ganglia of subjects 3 and 4.
DNA from purified VZV virions was also quantitated by competitive PCR. With either the gene 28 or gene 62 primers, 7 .309 x 109 copies of VZV DNA were detected in 1 ,ug of virion DNA (data not shown), in contrast to 9 to 53 copies of VZV DNA per ,ug in normal human trigeminal ganglia. Furthermore, 1 ,ug of VZV DNA (125 kbp) contains 7 x 109 molecules, which is in agreement with the quantity determined by competitive PCR. Each eukaryotic cell contains 6 x 10-6 ,ug of DNA (10) . We detected 9 to 53 copies of VZV DNA per ,ug of ganglionic DNA, or 6 x 10-5 to 31 X 10-VZV DNA molecules per cell. This corresponds to approximately 6 to 31 copies of VZV DNA in every 100,000 ganglionic cells. In normal human ganglia latently infected with herpes simplex virus type 1, approximately 1,000 to 10,000 copies of herpes simplex virus DNA have been detected in every 100,000 cells (2) . The relationship between the greater (166-to 322-fold) abundance of herpes simplex virus DNA than of VZV DNA in latently infected human ganglia and the frequent reactivation of herpes simplex virus in the young versus VZV reactivation in the elderly remains to be determined.
